Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets

Alessia Cimadamore, Marina Scarpelli, Francesco Piva, Francesco Massari, Silvia Gasparrini, Andrea Doria, Liang Cheng, Antonio Lopez-Beltran, Rodolfo Montironi

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Chemokines are a class of low-molecular-weight proteins that induce chemotaxis and are implicated in the modulation of angiogenesis. The imbalance among angiogenic and antiangiogenic chemokines can promote the development of several conditions, including chronic inflammation, dysplastic transformation and cancer. In this review, we describe the activity and clinical significance of chemokines in prostate and renal tumors and provide an update on ongoing studies in this setting.

Original languageEnglish (US)
Pages (from-to)1105-1114
Number of pages10
JournalFuture Oncology
Volume13
Issue number12
DOIs
StatePublished - May 1 2017

Fingerprint

Chemokines
Prostate
Kidney
Neoplasms
Chemotaxis
Therapeutics
Molecular Weight
Inflammation
Proteins

Keywords

  • angiogenesis
  • chemokines
  • prostate cancer
  • renal cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Cimadamore, A., Scarpelli, M., Piva, F., Massari, F., Gasparrini, S., Doria, A., ... Montironi, R. (2017). Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets. Future Oncology, 13(12), 1105-1114. https://doi.org/10.2217/fon-2016-0481

Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets. / Cimadamore, Alessia; Scarpelli, Marina; Piva, Francesco; Massari, Francesco; Gasparrini, Silvia; Doria, Andrea; Cheng, Liang; Lopez-Beltran, Antonio; Montironi, Rodolfo.

In: Future Oncology, Vol. 13, No. 12, 01.05.2017, p. 1105-1114.

Research output: Contribution to journalReview article

Cimadamore, A, Scarpelli, M, Piva, F, Massari, F, Gasparrini, S, Doria, A, Cheng, L, Lopez-Beltran, A & Montironi, R 2017, 'Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets', Future Oncology, vol. 13, no. 12, pp. 1105-1114. https://doi.org/10.2217/fon-2016-0481
Cimadamore A, Scarpelli M, Piva F, Massari F, Gasparrini S, Doria A et al. Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets. Future Oncology. 2017 May 1;13(12):1105-1114. https://doi.org/10.2217/fon-2016-0481
Cimadamore, Alessia ; Scarpelli, Marina ; Piva, Francesco ; Massari, Francesco ; Gasparrini, Silvia ; Doria, Andrea ; Cheng, Liang ; Lopez-Beltran, Antonio ; Montironi, Rodolfo. / Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets. In: Future Oncology. 2017 ; Vol. 13, No. 12. pp. 1105-1114.
@article{796353f7cfdc46abb89b5f74b2a66a1b,
title = "Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets",
abstract = "Chemokines are a class of low-molecular-weight proteins that induce chemotaxis and are implicated in the modulation of angiogenesis. The imbalance among angiogenic and antiangiogenic chemokines can promote the development of several conditions, including chronic inflammation, dysplastic transformation and cancer. In this review, we describe the activity and clinical significance of chemokines in prostate and renal tumors and provide an update on ongoing studies in this setting.",
keywords = "angiogenesis, chemokines, prostate cancer, renal cancer",
author = "Alessia Cimadamore and Marina Scarpelli and Francesco Piva and Francesco Massari and Silvia Gasparrini and Andrea Doria and Liang Cheng and Antonio Lopez-Beltran and Rodolfo Montironi",
year = "2017",
month = "5",
day = "1",
doi = "10.2217/fon-2016-0481",
language = "English (US)",
volume = "13",
pages = "1105--1114",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "12",

}

TY - JOUR

T1 - Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets

AU - Cimadamore, Alessia

AU - Scarpelli, Marina

AU - Piva, Francesco

AU - Massari, Francesco

AU - Gasparrini, Silvia

AU - Doria, Andrea

AU - Cheng, Liang

AU - Lopez-Beltran, Antonio

AU - Montironi, Rodolfo

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Chemokines are a class of low-molecular-weight proteins that induce chemotaxis and are implicated in the modulation of angiogenesis. The imbalance among angiogenic and antiangiogenic chemokines can promote the development of several conditions, including chronic inflammation, dysplastic transformation and cancer. In this review, we describe the activity and clinical significance of chemokines in prostate and renal tumors and provide an update on ongoing studies in this setting.

AB - Chemokines are a class of low-molecular-weight proteins that induce chemotaxis and are implicated in the modulation of angiogenesis. The imbalance among angiogenic and antiangiogenic chemokines can promote the development of several conditions, including chronic inflammation, dysplastic transformation and cancer. In this review, we describe the activity and clinical significance of chemokines in prostate and renal tumors and provide an update on ongoing studies in this setting.

KW - angiogenesis

KW - chemokines

KW - prostate cancer

KW - renal cancer

UR - http://www.scopus.com/inward/record.url?scp=85019693957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019693957&partnerID=8YFLogxK

U2 - 10.2217/fon-2016-0481

DO - 10.2217/fon-2016-0481

M3 - Review article

C2 - 28147707

AN - SCOPUS:85019693957

VL - 13

SP - 1105

EP - 1114

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 12

ER -